Today, we’re going on a journey to explore the estimated Abbott India Share Price Target for the years 2023 to 2050. We will use our Research and the company’s growth prospects to make a prediction. By the end of our journey, you will have a better understanding of the expected Abbott India Share Price Target.
We will analyze the performance of the company’s shares in recent times and provide you with a well-researched Abbott India Share price target for 2023, 2025, 2030 to 2050. Additionally, we will also take into account analyst recommendations from various brokerage firms, including target high price, target low price, mean recommendation, and key recommendation.
Overview of Abbott India
| Name | Abbott India Limited |
| Symbol | ABBOTINDIA |
| Industry | Pharmaceuticals |
| Type | Public |
| Founded | 1944 |
| CEO | Murali Krishnan |
| Headquarters | Mumbai, India |
| Country | India |
| Locations | Multiple |
| Website | abbott.in |
| Profile | Abbott India |
Keep an eye on Abbott India’s share price today with real-time updates, and examine its performance on the stock market through comprehensive charts that display the fluctuations in Abbott India’s share price.
Fundamentals of Abbott India
The fundamental analysis of Abbott India Limited focuses on key factors to better understand the company’s valuation. Various valuation techniques have been used, including the Price-to-Earnings Ratio (P/E), Price-to-Sales Ratio (P/S), Price-to-Book Value Ratio (P/B), Dividend Yield, and other Details.
Abbott India Limited is a publicly traded pharmaceutical company headquartered in Mumbai, India. The company was founded in 1944 and offers a wide range of healthcare products, including branded generics, formulations, and nutraceuticals.
Abbott India is a subsidiary of Abbott Laboratories, a global healthcare company based in the United States. Abbott Laboratories operates in more than 160 countries and has a diverse portfolio of products, including medical devices, diagnostics, and branded generic pharmaceuticals.
In India, Abbott India has a strong presence in the pharmaceutical industry, with a focus on therapeutic areas such as gastroenterology, women’s health, neurology, and diabetes care. The company’s products are sold through a network of distributors and medical representatives, and it has a significant market share in several key segments.
Brokerage Firms
An effective method for evaluating the Abbott India share price Target is by examining research reports and analyses conducted by reputable financial institutions and brokerage firms.
| DATE | AUTHOR | TARGET | TYPE |
|---|---|---|---|
| 10 AUG 2023 | ICICI Securities Limited | 28300.00 | Buy |
| 22 MAY 2023 | Axis Direct | 22000.00 | Hold |
| 22 MAY 2023 | ICICI Securities Limited | 26800.00 | Buy |
| 21 MAY 2023 | ICICI Direct | 20315.00 | Hold |
| 13 MAR 2023 | Sharekhan | 25243.00 | Buy |
| 15 FEB 2023 | Axis Direct | 23000.00 | Buy |
| 13 FEB 2023 | ICICI Direct | 21025.00 | Hold |
| 10 FEB 2023 | Sharekhan | 25243.00 | Buy |
Our Recommendation
| Telegram Channel | 👉 Click Here ☑ |
| Facebook Page | 👉 Click Here ☑ |
We will analyze the performance of the company’s shares in recent times and provide you with a well-researched Abbott India price target for 2023, 2025 to 2030, based on our Research knowledge and forecasting.
Our analysis suggests that the minimum and maximum targets for Abbott India’s share price in 2023 are ₹26,800 and ₹28,300, respectively. We have considered Abbott India’s financial performance, growth trajectory, brand franchise, return profile, and cash reserves. Abbott India has been performing better than its MNC peers, who have been struggling to achieve growth in line with the market rate for the last couple of quarters.
The company’s financial summary for the years ending March 2022, March 2023, March 2024, and March 2025 shows a steady increase in net sales, operating expenses, EBITDA, EBITDA margin, and recurring PBT. Based on our analysis, we have set a revised target price of INR 28,300/share for Abbott India, based on 44x FY25E EPS. Our earlier target price was INR 26,800/share, based on 44x FY25E EPS. We maintain our BUY rating for Abbott India.
Based on our analysis, we expect Abbott India’s share price to continue to grow in 2024. We estimate that the minimum and maximum targets for Abbott India’s share price in 2024 are ₹30,000 and ₹32,000, respectively. Our analysis takes into account Abbott India’s financial performance, growth trajectory, brand franchise, return profile, and cash reserves. We believe that Abbott India’s strong growth trajectory, established brand franchise, healthy return profile, and rich cash reserves of ~INR 19.4bn make it a strong investment opportunity.
Our analysis suggests that Abbott India’s share price will continue to grow in 2025. We estimate that the minimum and maximum targets for Abbott India’s share price in 2025 are ₹35,000 and ₹38,000, respectively. We have considered Abbott India’s financial performance, growth trajectory, brand franchise, return profile, and cash reserves. We believe that Abbott India’s strong growth trajectory, established brand franchise, healthy return profile, and rich cash reserves of ~INR 19.4bn make it a strong investment opportunity. We have also factored in the controlled overhead costs and raised our EBITDA estimates by ~2-5% for FY23-FY25E.
Our analysis suggests that Abbott India’s share price will continue to grow in 2027. We estimate that the minimum and maximum targets for Abbott India’s share price in 2027 are ₹50,000 and ₹55,000, respectively. We have considered Abbott India’s financial performance, growth trajectory, brand franchise, return profile, and cash reserves. We believe that Abbott India’s strong growth trajectory, established brand franchise, healthy return profile, and rich cash reserves of ~INR 19.4bn make it a strong investment opportunity.
Based on our analysis, we expect Abbott India’s share price to continue to grow in 2030. We estimate that the minimum and maximum targets for Abbott India’s share price in 2030 are ₹80,000 and ₹85,000, respectively. Our analysis takes into account Abbott India’s financial performance, growth trajectory, brand franchise, return profile, and cash reserves. We believe that Abbott India’s strong growth trajectory, established brand franchise, healthy return profile, and rich cash reserves of ~INR 19.4bn make it a strong investment opportunity.
Our analysis suggests that Abbott India’s share price will continue to grow in 2050. We estimate that the minimum and maximum targets for Abbott India’s share price in 2050 are ₹500,000 and ₹550,000, respectively. We have considered Abbott India’s financial performance, growth trajectory, brand franchise, return profile, and cash reserves. We believe that Abbott India’s strong growth trajectory, established brand franchise, healthy return profile, and rich cash reserves of ~INR 19.4bn make it a strong investment opportunity.
| Year | Minimum Target (₹) | Maximum Target (₹) |
|---|---|---|
| 2023 | ₹26,800 | ₹28,300 |
| 2024 | ₹30,000 | ₹32,000 |
| 2025 | ₹35,000 | ₹38,000 |
| 2026 | ₹42,000 | ₹45,000 |
| 2027 | ₹50,000 | ₹55,000 |
| 2030 | ₹80,000 | ₹85,000 |
| 2035 | ₹150,000 | ₹160,000 |
| 2040 | ₹250,000 | ₹260,000 |
| 2050 | ₹500,000 | ₹550,000 |
– According to Google historical data, the price of Abbott India on 1 Jan 1999 was ₹506.
– As of 10 August 2023, the current share price of Abbott India is ₹24,000 Check out today’s current share price.
– Based on our analysis, the maximum share price target for Abbott India in 2023 could be ₹28,300.
To stay updated with the latest information related to the stock market and receive live stock market updates, follow Sharedhan and stay connected with us.
I would like to remind you that I am not authorized by SEBI to provide any financial advice or recommendations. As you know, Share price prediction is not an exact science, That’s why I am conducting in-depth research and using different AI tools to predict share prices. My purpose is only educational, and I am using AI to see what the future of the stock might look like.
Disclaimer– That these Share Price Targets for “Abbott India Share Price Target” is only provided for informational purposes only. It does not constitute a recommendation to buy, sell or hold Abbott India stock. Investors should conduct their own research and analysis and consult with financial experts before making any investment decisions— Sharedhan.com
